Be on schedule.Score better.

EN

Perez is experiencing

  • Given her weight (less than 60      kg), Campral should have been started at 666 mg orally BID. It is possible      that the higher dose may be responsible for the severity of the symptoms      that Mrs. Perez is experiencing.
  • Technically, the drug should      have been stopped (not simply decreased) once Mrs. Perez reported suicidal      ideation. Even with the decrease in dose, she is still having suicidal      ideation, which indicates the need to discontinue the drug. Although      controversy exists regarding how long to use pharmacologic approaches to      treatment of alcohol dependence, 8 weeks is probably insufficient,      therefore, the drug should not simply be discontinued without using a      different agent in its place.
  • Mrs. Perez should be started on      Antabuse at 250 mg orally daily and referred to psychotherapy to address      her gambling issue.
  • In all cases, the PMHNP needs      to discuss smoking cessation options with Mrs. Perez in order to address      the totality of addictions and to enhance her overall health. The decision      to begin Wellbutrin XL 150 mg orally daily may help achieve this goal, but      this choice does not address her abstinence from alcohol.
  • Additionally, it should be      noted that although Mrs. Perez reports that she has been avoiding the      casino secondary to her fear that she will drink, this “fear” has not      actually treated her gambling addiction. This particular addiction has      resulted in considerable personal financial cost to Ms. Perez. Mrs. Perez      needs to be referred to a counselor who specializes in the treatment of      gambling disorder, and she should also be encouraged to establish herself      with a local chapter of Gamblers Anonymous.
  • Examine Case Study: A      Puerto Rican Woman With Comorbid Addiction. You will be asked to make      three decisions concerning the medication to prescribe to this client. Be      sure to consider factors that might impact the client’s pharmacokinetic      and pharmacodynamic processes.
  • At each decision point stop to      complete the following:
  • Decision #1
  • Which decision did you select?
  • Why did you select this      decision? Support your response with evidence and references to the      Learning Resources.
  • What were you hoping to achieve      by making this decision? Support your response with evidence and      references to the Learning Resources.
  • Explain any difference between      what you expected to achieve with Decision #1 and the results of the      decision. Why were they different?
  • Decision #2
  • Why did you select this      decision? Support your response with evidence and references to the      Learning Resources.
  • What were you hoping to achieve      by making this decision? Support your response with evidence and      references to the Learning Resources.
  • Explain any difference between      what you expected to achieve with Decision #2 and the results of the      decision. Why were they different?
  • Decision #3
  • Why did you select this      decision? Support your response with evidence and references to the      Learning Resources.
  • What were you hoping to achieve      by making this decision? Support your response with evidence and      references to the Learning Resources.
  • Explain any difference between      what you expected to achieve with Decision #3 and the results of the      decision. Why were they different?

 

edit this or redo other assignment.

 

Assessing and Treating Clients with Impulsivity, Compulsivity and Addiction 

Pharmacotherapy practice to treating substance use disorders is often referred to as medication assisted treatment (MAT) (Sharp et al., 2018). In this practice, specific medications approved by Federal Drug Administration (FDA) are used in combination with counseling and behavioral therapies in treatment of a substance use disorder (Sharp et al, 2018) Medications can reduce the cravings and other symptoms associated with withdrawal from a substance by occupying receptors in the brain associated with using that drug (agonists or partial agonists), block the rewarding sensation that comes with using a substance (antagonists), or induce negative feelings when a substance is taken ( SAMHSA, 2016). MAT has been primarily used for the treatment of opioid use disorder but is also used for alcohol use disorder and the treatment of some other substance use disorders. This paper focuses on pharmacotherapy approaches to treatment of alcohol use disorder, gambling disorder and smoking addiction in a 53 year- old female of Puerto origin.

Case Scenario

Table of Contents

[display_short_calculator]

Latest Reviews

Impressed with the sample above? Wait there is more

Related Questions

For Rey Writer

Answer in complete sentences Chapter Lecture Activity 1. Explain Erikson’s stage of Identity vs. Role Confusion. How can you identify with this stage (either currently or in your

Was the sample for this study

1.  What demographic variables were measured at the nominal level of measurement in the Oh et al. (2014) study? Provide a rationale for your answer.

New questions

learners final paper

diverese Week 5 – Final Paper Ashford University Assignment Submision Week 5 Final Paper Classroom Scenario Analysis To make curriculum accessible to English language learners

Don't Let Questions or Concerns Hold You Back - Make a Free Inquiry Now!